Michael Alifrangis

Michael Alifrangis

Associate Professor

Member of:

  • DRUGS team


  1. 2002
  2. Published

    Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe

    Jelinek, T., Peyerl-Hoffmann, G., Mühlberger, N., Wichmann, O., Wilhelm, M., Schmider, N., Grobusch, M. P., von Sonnenburg, F., Gascon, J., Laferl, H., Hatz, C., Alifrangis, M., Burchard, G., McWhinney, P., Schulze, M., Kollaritsch, H., da Cunha, S., Beran, J., Kern, P., Gjørup, I. & 1 others, Cuadros, J., 2002, In: Malaria Journal. 1, p. 11

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome

    Khalil, I., Alifrangis, Michael, Rønn, A. M., Gabar, H. A., Jelinek, T., Satti, G. M. H. & Bygbjerg, Ib Christian, 2002, In: American Journal of Tropical Medicine and Hygiene. 67, 3, p. 225-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 1999
  5. Published

    IgG reactivities against recombinant Rhoptry-Associated Protein-1 (rRAP-1) are associated with mixed Plasmodium infections and protection against disease in Tanzanian children

    Alifrangis, Michael, Lemnge, M. M., Moon, R., Theisen, Michael, Bygbjerg, Ib Christian, Ridley, R. G. & Jakobsen, P. H., 1999, In: Parasitology. 119 ( Pt 4), p. 337-42 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...14 15 16 17 18 Next

ID: 11975